During the past decade, TASK Applied Sciences conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 9 clinical trials were completed, i.e. on average, 56.3% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 5 clinical trials were completed. i.e. 55.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "TASK Applied Sciences" #1 sponsor was "Global Alliance for TB Drug Development" with 4 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 3 trials sponsored, "Janssen Vaccines & Prevention B.V." with 2 trials sponsored, "Michael Hoelscher" with 2 trials sponsored and "Radboud University Medical Center" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "TASK Applied Sciences" #1 collaborator was "European and Developing Countries Clinical Trials Partnership (EDCTP)" with 3 trials as a collaborator, "Bio Analytical Research Corporation" with 2 trials as a collaborator, "BioVac" with 2 trials as a collaborator, "Biocair" with 2 trials as a collaborator and "Clinical Laboratory Services" with 2 trials as a collaborator. Other collaborators include 32 different institutions and companies that were collaborators in the rest 33 trials.

According to Clinical.Site data, the most researched conditions in "TASK Applied Sciences" are "Pulmonary Tuberculosis" (4 trials), "Tuberculosis" (4 trials), "Tuberculosis, Pulmonary" (4 trials), "HIV Infections" (2 trials) and "Tuberculosis, MDR" (2 trials). Many other conditions were trialed in "TASK Applied Sciences" in a lesser frequency.

Most popular intervention types in "TASK Applied Sciences" are "Drug" (14 trials), "Biological" (6 trials), "Other" (3 trials), "Dietary Supplement" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Moxifloxacin" (3 trials), "Rifampicin" (3 trials), "Bedaquiline" (2 trials) and "PA-824" (2 trials). Other intervention names were less common.

The vast majority of trials in "TASK Applied Sciences" are 21 trials for "All" genders.

Currently, there are NaN active trials in "TASK Applied Sciences". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in TASK Applied Sciences, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in TASK Applied Sciences, 1 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".